Bruhn Suzanne Louise
SEC insider (Form 3/4/5 filer). CIK 0001517790. Director at Definium Therapeutics, Inc. (DFTX) and 3 other issuers. 8 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in NEW YORK, NY.
Companies Bruhn Suzanne Louise has filed insider reports for
- Definium Therapeutics, Inc. (DFTX): Director
- Travere Therapeutics, Inc. (TVTX): Director
- Vigil Neuroscience, Inc. (VIGL): Director
- PLIANT THERAPEUTICS, INC. (PLRX): Director
Bruhn Suzanne Louise
CIK: 0001517790
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jun 11, 2026DFTX
Definium Therapeutics, Inc.
AwardDirect4.7K shares- - May 19, 2026TVTX
Travere Therapeutics, Inc.
AwardDirect4K shares- - Aug 5, 2025VIGL
Vigil Neuroscience, Inc.
DispositionDirect5K shares- - Jun 12, 2025MNMD
Mind Medicine (MindMed) Inc.
AwardDirectStock Option (Right to Buy)
75.2K shares- - Jun 5, 2025PLRX
PLIANT THERAPEUTICS, INC.
AwardDirectCommon Stock (Right to Buy)
30K shares- - May 22, 2025VIGL
Vigil Neuroscience, Inc.
AwardDirect5K shares- - May 15, 2025TVTX
Travere Therapeutics, Inc.
AwardDirect6.5K shares- - Mar 3, 2025VIGL
Vigil Neuroscience, Inc.
AwardDirectStock Option Award (Right to Buy)
33.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  DFTX Definium Therapeutics, Inc. | Award | 4,666 | - | $0 | Direct |
| May 19, 2026 |  TVTX Travere Therapeutics, Inc. | Award | 4,000 | - | $0 | Direct |
| Aug 5, 2025 |  VIGL Vigil Neuroscience, Inc. | Disposition | 5,000 | - | - | Direct |
| Jun 12, 2025 |  MNMD Mind Medicine (MindMed) Inc. | Award Stock Option (Right to Buy) | 75,187 | - | - | Direct |
| Jun 5, 2025 |  PLRX PLIANT THERAPEUTICS, INC. | Award Common Stock (Right to Buy) | 30,000 | - | - | Direct |
| May 22, 2025 | VIGL Vigil Neuroscience, Inc. | Award | 5,000 | - | - | Direct |
| May 15, 2025 | TVTX Travere Therapeutics, Inc. | Award | 6,500 | - | - | Direct |
| Mar 3, 2025 | VIGL Vigil Neuroscience, Inc. | Award Stock Option Award (Right to Buy) | 33,875 | - | - | Direct |
1-8 of 8 transactions